AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,456,000 | +108.6% | 4,855,005 | +3.4% | 1.46% | +101.4% |
| Q2 2022 | $35,213,000 | -17.6% | 4,695,020 | 0.0% | 0.73% | -24.0% |
| Q1 2022 | $42,725,000 | +29.6% | 4,695,020 | 0.0% | 0.96% | +38.2% |
| Q4 2021 | $32,959,000 | -2.9% | 4,695,020 | +57.7% | 0.69% | +4.4% |
| Q3 2021 | $33,938,000 | +156.7% | 2,977,020 | +260.4% | 0.66% | +181.7% |
| Q2 2021 | $13,223,000 | +49.7% | 825,937 | +67.1% | 0.24% | +26.3% |
| Q1 2021 | $8,832,000 | -43.7% | 494,216 | -57.5% | 0.19% | -40.0% |
| Q4 2020 | $15,699,000 | +169.9% | 1,162,033 | +135.1% | 0.31% | +118.3% |
| Q3 2020 | $5,817,000 | -20.3% | 494,216 | 0.0% | 0.14% | -33.0% |
| Q2 2020 | $7,295,000 | -78.7% | 494,216 | -80.5% | 0.21% | -80.5% |
| Q1 2020 | $34,184,000 | -24.6% | 2,532,147 | +35.0% | 1.08% | -25.0% |
| Q4 2019 | $45,344,000 | -48.4% | 1,876,055 | -58.9% | 1.45% | -59.6% |
| Q3 2019 | $87,813,000 | -2.0% | 4,568,824 | +50.6% | 3.58% | +11.2% |
| Q2 2019 | $89,625,000 | +17.3% | 3,032,987 | +88.5% | 3.22% | +9.9% |
| Q1 2019 | $76,417,000 | +39.4% | 1,608,785 | +5.9% | 2.93% | +33.5% |
| Q4 2018 | $54,821,000 | -42.2% | 1,518,596 | -1.4% | 2.19% | -35.4% |
| Q3 2018 | $94,815,000 | +190.0% | 1,540,448 | +218.2% | 3.40% | +195.8% |
| Q2 2018 | $32,698,000 | +24.5% | 484,055 | 0.0% | 1.15% | +26.2% |
| Q1 2018 | $26,260,000 | -9.2% | 484,055 | 0.0% | 0.91% | -20.0% |
| Q4 2017 | $28,922,000 | -5.9% | 484,055 | -23.5% | 1.14% | -17.8% |
| Q3 2017 | $30,749,000 | -39.1% | 632,686 | -34.2% | 1.38% | -48.6% |
| Q2 2017 | $50,508,000 | +40.0% | 961,147 | +20.8% | 2.69% | +93.5% |
| Q1 2017 | $36,087,000 | -48.2% | 795,743 | -56.7% | 1.39% | -51.4% |
| Q4 2016 | $69,600,000 | +37.7% | 1,838,829 | +37.3% | 2.86% | +21.9% |
| Q3 2016 | $50,527,000 | +13.9% | 1,338,829 | -46.9% | 2.35% | +34.8% |
| Q2 2016 | $44,362,000 | +38.6% | 2,520,585 | -4.3% | 1.74% | +27.9% |
| Q1 2016 | $32,011,000 | +62.7% | 2,632,482 | +225.9% | 1.36% | +71.0% |
| Q4 2015 | $19,672,000 | +37.3% | 807,875 | 0.0% | 0.80% | +43.9% |
| Q3 2015 | $14,332,000 | -63.3% | 807,875 | -63.5% | 0.55% | -57.4% |
| Q2 2015 | $39,036,000 | +105.5% | 2,211,644 | +264.9% | 1.30% | +111.4% |
| Q1 2015 | $18,996,000 | -65.0% | 606,118 | -67.4% | 0.62% | -68.4% |
| Q4 2014 | $54,262,000 | +12.8% | 1,858,917 | -20.0% | 1.95% | +11.2% |
| Q3 2014 | $48,103,000 | +43.8% | 2,324,917 | +72.1% | 1.75% | +30.2% |
| Q2 2014 | $33,461,000 | +179.4% | 1,350,850 | +139.0% | 1.35% | +175.3% |
| Q1 2014 | $11,976,000 | +122.3% | 565,180 | +88.4% | 0.49% | +75.3% |
| Q4 2013 | $5,388,000 | – | 300,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|